9498941

Source:http://linkedlifedata.com/resource/pubmed/id/9498941

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0033744, umls-concept:C0036043, umls-concept:C0205272, umls-concept:C0722880, umls-concept:C1979963, umls-concept:C2003903, umls-concept:C2348205
pubmed:issue	2
pubmed:dateCreated	1998-3-10
pubmed:abstractText	As a secondary objective to a long-term study evaluating the bronchodilator effectiveness of Proventil HFA (albuterol), to assess the safety of Proventil HFA, Ventolin, and hydrofluoroalkane 134a (HFA-134a) placebo over 12 weeks of regular dosing.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0231335
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Adrenergic beta-Agonists, http://linkedlifedata.com/resource/pubmed/chemical/Aerosol Propellants, http://linkedlifedata.com/resource/pubmed/chemical/Albuterol, http://linkedlifedata.com/resource/pubmed/chemical/Bronchodilator Agents, http://linkedlifedata.com/resource/pubmed/chemical/HFA 134a, http://linkedlifedata.com/resource/pubmed/chemical/Hydrocarbons, Fluorinated, http://linkedlifedata.com/resource/pubmed/chemical/Placebos
pubmed:status	MEDLINE
pubmed:month	Feb
pubmed:issn	0012-3692
pubmed:author	pubmed-author:BleeckerE RER, pubmed-author:ColiceG LGL, pubmed-author:EkholmB PBP, pubmed-author:KlingerN MNM, pubmed-author:RamsdellJJ, pubmed-author:SladeH BHB, pubmed-author:TinkelmanD GDG
pubmed:issnType	Print
pubmed:volume	113
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	290-6
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:9498941-Administration, Inhalation, pubmed-meshheading:9498941-Adolescent, pubmed-meshheading:9498941-Adrenergic beta-Agonists, pubmed-meshheading:9498941-Adult, pubmed-meshheading:9498941-Aerosol Propellants, pubmed-meshheading:9498941-Aged, pubmed-meshheading:9498941-Albuterol, pubmed-meshheading:9498941-Asthma, pubmed-meshheading:9498941-Blood Cell Count, pubmed-meshheading:9498941-Blood Chemical Analysis, pubmed-meshheading:9498941-Blood Pressure, pubmed-meshheading:9498941-Bronchodilator Agents, pubmed-meshheading:9498941-Double-Blind Method, pubmed-meshheading:9498941-Headache, pubmed-meshheading:9498941-Heart Rate, pubmed-meshheading:9498941-Humans, pubmed-meshheading:9498941-Hydrocarbons, Fluorinated, pubmed-meshheading:9498941-Longitudinal Studies, pubmed-meshheading:9498941-Medical Records, pubmed-meshheading:9498941-Middle Aged, pubmed-meshheading:9498941-Peak Expiratory Flow Rate, pubmed-meshheading:9498941-Placebos, pubmed-meshheading:9498941-Respiratory Tract Infections, pubmed-meshheading:9498941-Rhinitis, pubmed-meshheading:9498941-Safety, pubmed-meshheading:9498941-Sleep Disorders
pubmed:year	1998
pubmed:articleTitle	Proventil HFA and ventolin have similar safety profiles during regular use.
pubmed:affiliation	Department of Medicine, University of Maryland, Baltimore, USA.
pubmed:publicationType	Journal Article, Clinical Trial, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study